StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2018, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 19 Apr 2018 09:53:32 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Shire Pic (SHPGY) call put ratio 5.9 calls to 1 put http://www.streetinsider.com/Options/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html Visit StreetInsider.com at http://www.streetinsider.com/Options/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html for the full story. http://www.streetinsider.com/Options/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html Thu, 19 Apr 2018 09:53:32 -0400 SHPGY Shire Pic (SHPGY) call put ratio 5.9 calls to 1 put http://www.streetinsider.com/Trader+Talk/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html Visit StreetInsider.com at http://www.streetinsider.com/Trader+Talk/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html for the full story. http://www.streetinsider.com/Trader+Talk/Shire+Pic+%28SHPGY%29+call+put+ratio+5.9+calls+to+1+put/14072859.html Thu, 19 Apr 2018 09:53:32 -0400 SHPGY Halozyme Therapeutics (HALO) Taps Shire's (SHPGY) Stelzer as CFO http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html for the full story. http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Fri, 05 Jun 2015 09:01:38 -0400 HALO SHPGY Halozyme Therapeutics (HALO) Taps Shire's (SHPGY) Stelzer as CFO http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html for the full story. http://www.streetinsider.com/Management+Changes/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Fri, 05 Jun 2015 09:01:38 -0400 HALO SHPGY Halozyme Therapeutics (HALO) Taps Shire's (SHPGY) Stelzer as CFO http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html for the full story. http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Fri, 05 Jun 2015 09:01:38 -0400 HALO SHPGY Halozyme Therapeutics (HALO) Taps Shire's (SHPGY) Stelzer as CFO http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html for the full story. http://www.streetinsider.com/Management+Comments/Halozyme+Therapeutics+%28HALO%29+Taps+Shire%27s+%28SHPGY%29+Stelzer+as+CFO/10628870.html Fri, 05 Jun 2015 09:01:38 -0400 HALO SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Hedge+Funds/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Litigation/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Kyle Bass, Others May Lose Ability to Challenge Drug Patents (ABBV) (HZNP) (CELG) http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Visit StreetInsider.com at http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html for the full story. http://www.streetinsider.com/Short+Sales/Kyle+Bass%2C+Others+May+Lose+Ability+to+Challenge+Drug+Patents+%28ABBV%29+%28HZNP%29+%28CELG%29/10626390.html Thu, 04 Jun 2015 12:52:06 -0400 ABBV BIIB CELG HZNP SHP SHPGY Impax (IPXL), Shire (SHPGY) Settle Litigation Tied to Generic Adderall XR http://www.streetinsider.com/Corporate+News/Impax+%28IPXL%29%2C+Shire+%28SHPGY%29+Settle+Litigation+Tied+to+Generic+Adderall+XR/8073328.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Impax+%28IPXL%29%2C+Shire+%28SHPGY%29+Settle+Litigation+Tied+to+Generic+Adderall+XR/8073328.html for the full story. http://www.streetinsider.com/Corporate+News/Impax+%28IPXL%29%2C+Shire+%28SHPGY%29+Settle+Litigation+Tied+to+Generic+Adderall+XR/8073328.html Fri, 08 Feb 2013 08:03:40 -0400 IPXL SHPGY